Brenda Edwards
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brenda Edwards
Earlier roles on record: CFO at InMed Pharmaceuticals Inc. (INM) until November 20, 2022. InMed Pharmaceuticals Inc. reported in an 8-K filed November 17, 2022 that Brenda Edwards was terminated as Interim Chief Financial Officer, effective November 20, 2022.
“On November 14, 2022, the Company terminated the Consulting Agreement for Brenda Edwards effective November 20, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-04-01–2022-11-20
-
Start not stated–2022-11-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.